Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03471481 · ClinicalTrials.gov registry record
Magnesium as a Mediator of Bone and Vitamin D Metabolism in Patients on Antiepileptic Drug Therapy
A clinical trial, sponsored by Drexel University.
- Terminated
- Registry status
- 7
- Enrollment target
NCT03471481: Clinical Trial study, sponsored by Drexel University.
NCT03471481 is a clinical trial that was terminated before completion, run by Drexel University. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03471481 was terminated before completion, sponsored by Drexel University.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
The objective of this study is to determine the role of magnesium on bone and vitamin D metabolism in patients receiving anti-epileptic medications.
Primary Outcome
Will be measured at Tibia, Hip and Total Body using a DXA scan
Interventions
- OTHER No Intervention. Study is Cross Sectional in nature
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2015-08-10 |
| Est. Completion | 2019-08-01 |
Why NCT03471481 stopped before completion
NCT03471481 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No Intervention. Study is Cross Sectional in nature is the first listed.
NCT03471481 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03471481 about?
NCT03471481 is a clinical study titled "Magnesium as a Mediator of Bone and Vitamin D Metabolism in Patients on Antiepileptic Drug Therapy". The objective of this study is to determine the role of magnesium on bone and vitamin D metabolism in patients receiving anti-epileptic medications.
What is the current status of trial NCT03471481?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2015-08-10. Estimated completion is 2019-08-01.
What interventions are being tested in trial NCT03471481?
The interventions under investigation include: No Intervention. Study is Cross Sectional in nature (OTHER).
Who is sponsoring clinical trial NCT03471481?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI